Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

APC-111 MP Tablet Once a Day vs.Penicillin VK Four Times a Day Both for 10 Days in Patients With Strep Throat

ClinicalTrials.gov ID: NCT00242281

Public ClinicalTrials.gov record NCT00242281. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 5:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Multicenter Study to Evaluate the Safety/Efficacy of APC-111 MP Tablet QD vs. Penicillin VK QID Both for 10 Days Treatment of Pharyngitis Secondary to S.Pyogenes in Adolescents/Adults

Study identification

NCT ID
NCT00242281
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Advancis Pharmaceutical Corporation
Industry
Enrollment
600 participants

Conditions and interventions

Interventions

  • APC-111 MP Tablet, 775 mg Drug

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2005
Primary completion
Not listed
Completion
Jun 30, 2006
Last update posted
Oct 24, 2006

2005 – 2006

United States locations

U.S. sites
35
U.S. states
22
U.S. cities
35
Facility City State ZIP Site status
Not listed Birmingham Alabama
Not listed Tallassee Alabama
Not listed Phoenix Arizona
Not listed Carmichael California
Not listed Laguna Niguel California
Not listed San Luis Obispo California
Not listed Littleton Colorado
Not listed DeLand Florida
Not listed Conyers Georgia
Not listed Boise Idaho
Not listed Overland Park Kansas
Not listed Topeka Kansas
Not listed Wichitia Kansas
Not listed Bardstown Kentucky
Not listed Milford Massachusetts
Not listed New Bedford Massachusetts
Not listed Kalamazoo Michigan
Not listed Butte Montana
Not listed Omaha Nebraska
Not listed Johnson City New York
Not listed Burlington North Carolina
Not listed Simpsonville North Carolina
Not listed Canfield Ohio
Not listed North Wales Pennsylvania
Not listed Scotland Pennsylvania
Not listed Shippensburg Pennsylvania
Not listed Bristol Tennessee
Not listed Kingsport Tennessee
Not listed San Antonio Texas
Not listed Bountiful Utah
Not listed Salt Lake City Utah
Not listed West Jordan Utah
Not listed Newport News Virginia
Not listed Edmonds Washington
Not listed Wenatchee Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00242281, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 24, 2006 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00242281 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →